Therapeutic apheresis - State of the art in the year 2005

Therapeutic Apheresis and Dialysis

Volumn 9, Issue 6, 2005, Pages 459-468

  Bosch, Thomas ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Dilative cardiomyopathy; Immunoadsorption; LDL apheresis; Leukocyte apheresis; Therapeutic apheresis

Indexed keywords

ADSORBENT; ALBUMIN; BLOOD GROUP ANTIGEN; CELLULOSE; CELLULOSE ACETATE; DEXTRAN SULFATE; HEPARIN; IMMUNOGLOBULIN ANTIBODY; IMMUNOGLOBULIN G; PHENYLALANINE; POLYACRYLIC ACID; POLYESTER; POLYMYXIN B; POLYPROPYLENE; POLYVINYL ALCOHOL; SEPHAROSE; STAPHYLOCOCCUS PROTEIN A; TRYPTOPHAN;

APHERESIS; ARTERY DISEASE; ARTICLE; BLOOD GROUP ABO INCOMPATIBILITY; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; CONGESTIVE CARDIOMYOPATHY; GUILLAIN BARRE SYNDROME; HUMAN; HYPERCHOLESTEROLEMIA; HYPOTENSION; IMMUNOADSORPTION; ISCHEMIC HEART DISEASE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LEUKAPHERESIS; LIVER FAILURE; LIVING DONOR; MULTIPLE SCLEROSIS; MYASTHENIA GRAVIS; PLASMAPHERESIS; PRIORITY JOURNAL; REGISTER; RETINA MACULA AGE RELATED DEGENERATION; RHEUMATOID ARTHRITIS; SAFETY; SUDDEN DEAFNESS; ULCERATIVE COLITIS; VASCULAR ACCESS; CONTROLLED CLINICAL TRIAL; INSTRUMENTATION; METHODOLOGY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REVIEW;

BLOOD COMPONENT REMOVAL; HUMANS; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS; REGISTRIES;

EID: 33645932638     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2005.00306.x     Document Type: Article

References (49)

1. Linenberger ML Price TH. Use of cellular and plasma apheresis in the critically ill patient: Part II. Clinical indications and applications. J Intensive Care Med 2005 20 : 88 103.
2. Shibuya N. Therapeutic apheresis for neurological diseases. Ther Apher 2000 4 : 261 2.
3. von Baeyer H. Plasmapheresis in immune hematology: review of clinical outcome data with respect to evidence-based medicine and clinical experience. Ther Apher Dial 2003 7 : 127 40.
4. Malchesky PS Koo AP Roberson GA Hadsell AT Rybicki LA. Apheresis technologies and clinical applications: the 2002 international apheresis registry. Ther Apher Dial 2004 8 : 124 43.
5. Mabuchi H Koizumi J Shimizu M, et al. Long-term efficacy of low-density lipoprotein apheresis on coronary heart disease in familial hypercholesterolemia. Hokuriku-FH-LDL-Apheresis Study Group. Am J Cardiol 1998 82 : 1489 95.
6. Samuelsson G. Extracorporeal immunoadsorption with protein A: technical aspects and clinical results. J Clin Apher 2001 16 : 49 52.
7. Braun N Bosch T. Immunoadsorption, current status and future developments. Expert Opin Invest Drugs 2000 9 : 2017 38.
8. Felson DT LaValley MP Baldassare AR Furst DE. The Prosorba column for treatment of refractory rheumatoid arthritis. Arthritis Rheumatism 1999 42 : 2153 9.
9. Ronspeck W Brinckmann R Egner R, et al. Peptide based adsorbers for therapeutic immunoadsorption. Ther Apher Dial 2003 7 : 91 7.
10. Klingel R Mausfeld P Fassbender C Goehlen B. Lipidfiltration - safe and effective methodology to perform lipid apheresis. Trans Apher Sci 2004 30 : 245 54.
11. Koll RA. LDL-Therasorb immunoadsorption for the treatment of severe hypercholesterolemia refractory to conventional therapy. Ther Apher 1998 2 : 142 6.
12. Asahi T Yamamoto T Kutsuki H. Blood purification therapies using dextran sulfate cellulose columns Liposorber and Selesorb. Ther Apher Dial 2003 7 : 73 7.
13. Bosch T Lennertz A Schenzle D Dräger J for the DALI Study Group. Direct adsorption of low-density lipoprotein and lipoprotein (a) from whole blood: results of the first clinical long-term multicenter study using DALI apheresis. J Clin Apher 2002 17 : 161 9.
14. Blessing F Wang Y Walli AK Seidel D. Heparin-mediated extracorporeal low-density lipoprotein precipitation: rationale for a specific adjuvant therapy in cardiovascular disease. Trans Apher Sci 2004 30 : 255 66.
15. Shimoyama T Sawada K Hiwatashi N, et al. Safety and efficacy of granulocyte and monocyte adsorption apheresis in patients with active ulcerative colitis: a multicenter study. J Clin Apher 2001 16 : 1 9.
16. Sawada K Muto T Shimoyama T, et al. Multicenter randomised controlled trial for the treatment of ulcerative colitis with a leucocytaperesis column. Curr Pharm Des 2003 9 : 307 21.
17. Mitzner S Klammt S Stange J Nöldge-Schomburg GFE Schmidt R. Extrakorporale Blutreiningung im schweren Leberversagen mit der Albumindialyse MARS - Einfluss auf intensivmedizinisch relevante Parameter. Anästhesiol Intensivmed Notfallmed Schmerzther 2005 40 : 199 206.
18. Falkenhagen D Strobl W Vogt G, et al. Fractionated plasma separation and adsorption system: a novel system for blood purification to remove albumin bound substances. Artif Organs 1999 23 : 81 6.
19. Sueoka A. Therapeutic apheresis application using membrane plasma fractionation technology. present scope and limitations. Ther Apher 2000 4 : 211 2.
20. Siami GA Siami FS. Current topics on cryofiltration technologies. Ther Apher 2001 5 : 283 6.
21. Tydén G Kumlien G Genberg H Sandberg J Lundgren T Fehrman I. ABO incompatible kidney transplantations without splenectomy, using antigen-specific immunoadsorption and rituximab. Am J Transplant 2005 5 : 145 8.
22. Gejyo F Kawaguchi Y Hara S, et al. Arresting dialysis-related amyloidosis: a prospective multicenter controlled trial of direct hemoperfusion with a beta2-microglobulin adsorption column. Artif Organs 2004 28 : 371 80.
23. Vincent JL Laterre PF Cohen J, et al. A pilot-controlled study of a polymyxin B immobilized hemoperfusion cartridge in patients with severe sepsis secondary to intra-abdominal infection. Shock 2005 23 : 400 5.
24. Pulido J Sanders D Winters JL Klingel R. Clinical outcomes and mechanism of action for rheopheresis treatment of age-related macular degeneration (AMD). J Clin Apher 2005 20 : 185 94.
25. Suckfüll M. for the hearing loss Study Group. Fibrinogen and LDL apheresis in treatment of sudden hearing loss: a randomised multicenter trial. Lancet 2002 360 : 1811 7.
26. Sasso EH Merrill C Furst TE. Immunoglobulin binding properties of the Prosorba immunadsorption column in treatment of rheumatoid arthritis. Ther Apher 2001 5 : 84 91.
27. Felix SB Staudt A Dörffel WV, et al. Haemodynamic effects of immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathy. JACC 2000 35 : 1590 8.
28. 1-adrenergic receptor by immunoadsorption therapy in dilated cardiomyopathy. J Autoimmun 2003 20 : 345 50.
29. Felix SB Staudt A Landsberger M, et al. Removal of cardiodepressant antibodies in dilated cardiomyopathy by immunoadsorption. J Am Coll Cardiol 2002 39 : 646 52.
30. Staudt A Staudt Y Dörr M, et al. Potential role of humoral immunity in cardiac dysfunction of patients suffering from dilated cardiomyopathy. J Am Coll Cardiol 2004 44 : 829 36.
31. Staudt A Böhm M Knebel F, et al. Potential role of autoantibodies belonging to the immunoglobulin G-3 subclass in cardiac dysfunction among patients with dilated cardiomyopathy. Circulation 2002 106 : 2448 53.
32. Mitzner S Stange J Klammt S, et al. Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomised, controlled clinical trial. Liver Transpl 2000 6 : 277 86.
33. Heemann U Treichel U Loock J, et al. Albumin dialysis in cirrhosis with superimposed acute liver injury: a prospective controlled study. Hepatology 2002 36 : 949 58.
34. Banayosy A Kizner L Schueler V Bergmeier S Cobaugh D Koerfer R. Role of MARS in patients suffering from hypoxic liver failure following cardiogenic shock after cardiac surgery (Abstract). J Hepatol 2003 38 : 35.
35. Khuroo MS Khuroo MS Farahat LC. Molecular adsorbent recirculating system for acute and acute-on-chronic liver failure: a meta-analysis. Liver Transplant 2004 10 : 1099 106.
36. Rifai K Ernst T Kretschmer U, et al. Prometheus - a new extracorporeal system for the treatment of liver failure. J Hepatol 2003 39 : 984 90.
37. Saniabadi AR Hanai H Takeuchi K, et al. Adacolumn, an adsorptive carrier based granulocyte and monocyte apheresis device for the treatment of inflammatory and refractory diseases associated with leucocytes. Ther Apher Dial 2003 7 : 48 59.
38. Winters JL Gloor JM Pineda AA Stegall MD Moore SB. Plasma exchange conditioning for ABO-incompatible renal transplantation. J Clin Apher 2004 19 : 79 85.
39. Lorenz M Regele H Schillinger M, et al. Peritransplant immunoadsorption: a strategy enabling transplantation in highly sensitized crossmatch-positive cadaveric kidney allograft recipients. Transplantation 2005 79 : 696 701.
40. Böhmig GH Regele H Exner M, et al. C4d-positive acute humoral renal allograft rejection: Effect of treatment by immunoadsorption. J Am Soc Nephrol 2001 12 : 2482 9.
41. Thompson GR. LDL apheresis. Atherosclerosis 2003 167 : 1 13.
42. Gordon BR Stein E Jones P Illingworth DR. Indications for low-density lipoprotein apheresis. Am J Cardiol 1994 74 : 1109 12.
43. Schettler V Wieland E Armstrong VW Kleinoeder T Grunewald RW Muller GA. Participants of the Gottingen Consensus Conferences. First steps toward the establishment of a German low-density lipoprotein-apheresis registry: recommendations for the indication and for quality management. Ther Apher 2002 6 : 381 3.
44. Bosch T. State of the art of lipid apheresis. Artif Organs 1996 20 : 292 5.
45. Bosch T Wendler T. Efficacy and safety of DALI-LDL-Apheresis in two patients treated with angiotensin II-receptor antagonist losartan. Ther Apher Dial 2004 8 : 269 74.
46. Otto C Kern P Bambauer R Kallert S Schwandt P Parhofer KG. Efficacy and safety of a new whole-blood low-density lipoprotein apheresis system (liposorber D) in severe hypercholesterolemia. Artif Organs 2003 27 : 1116 22.
47. Bosch T Wendler T. State of the art of low-density lipoprotein apheresis in the year 2003. Ther Apher Dial 2004 8 : 76 9.
48. Klingel R Fassbender T Fassbender C Gohlen B. From membrane differential filtration to lipidfiltration: technological progress in low-density lipoprotein apheresis. Ther Apher Dial 2003 7 : 350 8.
49. Matsuzaki M Hiramori K Imaizumi T et al. Intravascular ultrasound evaluation of coronary plaque regression by low density lipoprotein-apheresis in familial hypercholesterolemia: the low density lipoprotein- apheresis coronary morphlogy and reserve trial (LACMART). J Am Coll Cardiol 2002 40 : 2002 7.